A detailed history of Ingalls & Snyder LLC transactions in Sanofi stock. As of the latest transaction made, Ingalls & Snyder LLC holds 16,845 shares of SNY stock, worth $840,060. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,845
Previous 16,845 -0.0%
Holding current value
$840,060
Previous $817,000 18.85%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$43.13 - $54.79 $19,408 - $24,655
-450 Reduced 2.6%
16,845 $838,000
Q3 2023

Nov 02, 2023

BUY
$50.95 - $55.2 $10,190 - $11,040
200 Added 1.17%
17,295 $928,000
Q2 2023

Jul 27, 2023

SELL
$50.45 - $57.18 $20,180 - $22,872
-400 Reduced 2.29%
17,095 $921,000
Q1 2023

May 09, 2023

SELL
$45.86 - $54.45 $21,783 - $25,863
-475 Reduced 2.64%
17,495 $952,000
Q4 2022

Jan 31, 2023

BUY
$38.86 - $48.55 $250,452 - $312,904
6,445 Added 55.92%
17,970 $870,000
Q3 2022

Oct 21, 2022

SELL
$37.22 - $100.5 $22,332 - $60,300
-600 Reduced 4.95%
11,525 $438,000
Q2 2022

Aug 11, 2022

BUY
$48.99 - $57.46 $175,384 - $205,706
3,580 Added 41.9%
12,125 $607,000
Q1 2022

May 09, 2022

SELL
$48.48 - $53.65 $40,723 - $45,066
-840 Reduced 8.95%
8,545 $439,000
Q4 2021

Feb 11, 2022

BUY
$47.07 - $52.35 $34,831 - $38,739
740 Added 8.56%
9,385 $470,000
Q3 2021

Oct 27, 2021

SELL
$47.89 - $53.12 $33,523 - $37,184
-700 Reduced 7.49%
8,645 $417,000
Q2 2021

Aug 03, 2021

BUY
$49.36 - $54.25 $9,872 - $10,850
200 Added 2.19%
9,345 $492,000
Q1 2021

Apr 21, 2021

SELL
$45.46 - $50.51 $9,092 - $10,102
-200 Reduced 2.14%
9,145 $452,000
Q4 2020

Jan 27, 2021

BUY
$45.3 - $51.62 $26,047 - $29,681
575 Added 6.56%
9,345 $454,000
Q2 2020

Jul 31, 2020

SELL
$42.91 - $52.5 $8,582 - $10,500
-200 Reduced 2.23%
8,770 $448,000
Q4 2019

Jan 15, 2020

BUY
$44.25 - $50.86 $108,014 - $124,149
2,441 Added 37.39%
8,970 $450,000
Q3 2019

Oct 16, 2019

SELL
$40.34 - $46.64 $23,598 - $27,284
-585 Reduced 8.22%
6,529 $302,000
Q2 2019

Jul 11, 2019

SELL
$40.43 - $44.3 $28,341 - $31,054
-701 Reduced 8.97%
7,114 $308,000
Q3 2018

Oct 24, 2018

SELL
$40.0 - $44.84 $16,000 - $17,936
-400 Reduced 4.87%
7,815 $349,000
Q2 2018

Aug 10, 2018

SELL
$37.63 - $41.22 $13,132 - $14,385
-349 Reduced 4.08%
8,215 $329,000
Q1 2018

Apr 17, 2018

BUY
$38.98 - $45.76 $29,234 - $34,320
750 Added 9.6%
8,564 $343,000
Q4 2017

Jan 19, 2018

BUY
$42.86 - $50.61 $4,457 - $5,263
104 Added 1.35%
7,814 $336,000
Q3 2017

Oct 20, 2017

BUY
$47.04 - $50.34 $362,678 - $388,121
7,710
7,710 $384,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $125B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.